<!DOCTYPE html>
<html>
<head>
<meta http-equiv="X-UA-Compatible" content="IE=Edge" />
<meta charset="utf-8" />
</head>

<body style="margin: 0;">

<div id="p142" style="overflow: hidden; position: relative; background-color: white; width: 935px; height: 1210px;">

<!-- Begin shared CSS values -->
<style class="shared-css" type="text/css" >
.t {
	transform-origin: bottom left;
	z-index: 2;
	position: absolute;
	white-space: pre;
	overflow: visible;
	line-height: 1.5;
}
.text-container {
	white-space: pre;
}
@supports (-webkit-touch-callout: none) {
	.text-container {
		white-space: normal;
	}
}
</style>
<!-- End shared CSS values -->


<!-- Begin inline CSS -->
<style type="text/css" >

#t1_142{left:119px;bottom:1134px;letter-spacing:0.11px;word-spacing:0.02px;}
#t2_142{left:799px;bottom:1132px;letter-spacing:-0.08px;}
#t3_142{left:162px;bottom:1067px;letter-spacing:0.14px;}
#t4_142{left:254px;bottom:1067px;letter-spacing:0.11px;word-spacing:1.54px;}
#t5_142{left:162px;bottom:1050px;letter-spacing:0.12px;word-spacing:2.6px;}
#t6_142{left:162px;bottom:1032px;letter-spacing:0.1px;word-spacing:-0.03px;}
#t7_142{left:162px;bottom:1015px;letter-spacing:0.1px;word-spacing:0.02px;}
#t8_142{left:162px;bottom:997px;letter-spacing:0.12px;word-spacing:-0.12px;}
#t9_142{left:312px;bottom:997px;letter-spacing:0.11px;word-spacing:-0.12px;}
#ta_142{left:162px;bottom:979px;letter-spacing:0.1px;word-spacing:-0.06px;}
#tb_142{left:162px;bottom:962px;letter-spacing:0.11px;word-spacing:0.79px;}
#tc_142{left:643px;bottom:970px;letter-spacing:-0.03px;}
#td_142{left:656px;bottom:962px;letter-spacing:0.11px;word-spacing:0.8px;}
#te_142{left:162px;bottom:944px;letter-spacing:0.1px;word-spacing:0.02px;}
#tf_142{left:409px;bottom:952px;letter-spacing:-0.04px;}
#tg_142{left:419px;bottom:944px;letter-spacing:0.1px;word-spacing:0.02px;}
#th_142{left:162px;bottom:927px;letter-spacing:0.12px;}
#ti_142{left:210px;bottom:927px;letter-spacing:0.11px;word-spacing:0.76px;}
#tj_142{left:162px;bottom:909px;letter-spacing:0.12px;word-spacing:1.88px;}
#tk_142{left:162px;bottom:892px;letter-spacing:0.12px;word-spacing:4.54px;}
#tl_142{left:162px;bottom:874px;letter-spacing:0.11px;word-spacing:2.87px;}
#tm_142{left:162px;bottom:857px;letter-spacing:0.12px;word-spacing:2.92px;}
#tn_142{left:162px;bottom:839px;letter-spacing:0.11px;word-spacing:0.02px;}
#to_142{left:162px;bottom:821px;letter-spacing:0.13px;word-spacing:3.87px;}
#tp_142{left:340px;bottom:821px;letter-spacing:0.12px;word-spacing:3.87px;}
#tq_142{left:162px;bottom:804px;letter-spacing:0.12px;word-spacing:3.72px;}
#tr_142{left:162px;bottom:786px;letter-spacing:0.11px;word-spacing:0.54px;}
#ts_142{left:162px;bottom:769px;letter-spacing:0.12px;word-spacing:3.49px;}
#tt_142{left:162px;bottom:751px;letter-spacing:0.11px;word-spacing:0.02px;}
#tu_142{left:162px;bottom:733px;letter-spacing:0.11px;word-spacing:1.78px;}
#tv_142{left:162px;bottom:716px;letter-spacing:0.12px;word-spacing:4.08px;}
#tw_142{left:162px;bottom:698px;letter-spacing:0.1px;word-spacing:0.02px;}
#tx_142{left:162px;bottom:681px;letter-spacing:0.14px;}
#ty_142{left:299px;bottom:681px;letter-spacing:0.11px;word-spacing:1.63px;}
#tz_142{left:162px;bottom:663px;letter-spacing:0.12px;word-spacing:1.57px;}
#t10_142{left:162px;bottom:646px;letter-spacing:0.11px;word-spacing:-0.54px;}
#t11_142{left:162px;bottom:628px;letter-spacing:0.1px;word-spacing:0.03px;}
#t12_142{left:141px;bottom:571px;letter-spacing:0.14px;}
#t13_142{left:162px;bottom:550px;letter-spacing:0.14px;}
#t14_142{left:162px;bottom:516px;letter-spacing:0.13px;word-spacing:0.03px;}
#t15_142{left:263px;bottom:516px;letter-spacing:0.12px;word-spacing:0.03px;}
#t16_142{left:347px;bottom:524px;}
#t17_142{left:352px;bottom:516px;letter-spacing:0.1px;word-spacing:0.03px;}
#t18_142{left:162px;bottom:498px;letter-spacing:0.11px;word-spacing:0.03px;}
#t19_142{left:162px;bottom:463px;letter-spacing:0.28px;}
#t1a_142{left:253px;bottom:463px;letter-spacing:0.26px;word-spacing:-0.89px;}
#t1b_142{left:162px;bottom:446px;letter-spacing:0.27px;word-spacing:1.63px;}
#t1c_142{left:162px;bottom:428px;letter-spacing:0.27px;word-spacing:1.48px;}
#t1d_142{left:162px;bottom:410px;letter-spacing:0.26px;word-spacing:-0.01px;}
#t1e_142{left:162px;bottom:393px;letter-spacing:0.27px;word-spacing:0.02px;}
#t1f_142{left:162px;bottom:375px;letter-spacing:0.28px;word-spacing:-0.44px;}
#t1g_142{left:325px;bottom:375px;letter-spacing:0.26px;word-spacing:-0.45px;}
#t1h_142{left:162px;bottom:358px;letter-spacing:0.27px;word-spacing:-0.21px;}
#t1i_142{left:162px;bottom:340px;letter-spacing:0.27px;word-spacing:-0.61px;}
#t1j_142{left:162px;bottom:322px;letter-spacing:0.26px;word-spacing:0.03px;}
#t1k_142{left:162px;bottom:305px;letter-spacing:0.28px;}
#t1l_142{left:221px;bottom:305px;letter-spacing:0.27px;word-spacing:0.88px;}
#t1m_142{left:162px;bottom:287px;letter-spacing:0.27px;word-spacing:0.68px;}
#t1n_142{left:162px;bottom:270px;letter-spacing:0.26px;word-spacing:0.66px;}
#t1o_142{left:162px;bottom:252px;letter-spacing:0.27px;word-spacing:0.69px;}
#t1p_142{left:162px;bottom:235px;letter-spacing:0.27px;word-spacing:0.03px;}
#t1q_142{left:162px;bottom:217px;letter-spacing:0.28px;word-spacing:0.34px;}
#t1r_142{left:338px;bottom:217px;letter-spacing:0.25px;word-spacing:0.34px;}
#t1s_142{left:162px;bottom:200px;letter-spacing:0.28px;word-spacing:5.54px;}
#t1t_142{left:162px;bottom:182px;letter-spacing:0.28px;word-spacing:4.57px;}
#t1u_142{left:162px;bottom:164px;letter-spacing:0.27px;word-spacing:2.11px;}
#t1v_142{left:162px;bottom:147px;letter-spacing:0.26px;word-spacing:0.03px;}
#t1w_142{left:162px;bottom:129px;letter-spacing:0.3px;}
#t1x_142{left:296px;bottom:129px;letter-spacing:0.27px;word-spacing:1.55px;}
#t1y_142{left:162px;bottom:112px;letter-spacing:0.27px;word-spacing:0.03px;}

.s0_142{font-size:15px;font-family:TimesNewRomanPSMT_6e;color:#000;}
.s1_142{font-size:17px;font-family:Calibri_7k;color:#000;}
.s2_142{font-size:15px;font-family:TimesNewRomanPS-BoldMT_7s;color:#000;}
.s3_142{font-size:10px;font-family:TimesNewRomanPSMT_87;color:#000;}
.s4_142{font-size:18px;font-family:TimesNewRomanPS-BoldMT_7w;color:#000;}
</style>
<!-- End inline CSS -->

<!-- Begin embedded font definitions -->
<style id="fonts142" type="text/css" >

@font-face {
	font-family: Calibri_7k;
	src: url("fonts/Calibri_7k.woff") format("woff");
}

@font-face {
	font-family: TimesNewRomanPS-BoldMT_7s;
	src: url("fonts/TimesNewRomanPS-BoldMT_7s.woff") format("woff");
}

@font-face {
	font-family: TimesNewRomanPS-BoldMT_7w;
	src: url("fonts/TimesNewRomanPS-BoldMT_7w.woff") format("woff");
}

@font-face {
	font-family: TimesNewRomanPSMT_6e;
	src: url("fonts/TimesNewRomanPSMT_6e.woff") format("woff");
}

@font-face {
	font-family: TimesNewRomanPSMT_87;
	src: url("fonts/TimesNewRomanPSMT_87.woff") format("woff");
}

</style>
<!-- End embedded font definitions -->

<!-- Begin page background -->
<div id="pg142Overlay" style="width:100%; height:100%; position:absolute; z-index:1; background-color:rgba(0,0,0,0); -webkit-user-select: none;"></div>
<div id="pg142" style="-webkit-user-select: none;"><object width="935" height="1210" data="142/142.svg" type="image/svg+xml" id="pdf142" style="width:935px; height:1210px; -moz-transform:scale(1); z-index: 0;"></object></div>
<!-- End page background -->


<!-- Begin text definitions (Positioned/styled in CSS) -->
<div class="text-container"><span id="t1_142" class="t s0_142">Brain: Chemistry to Cognition </span><span id="t2_142" class="t s1_142">134 </span>
<span id="t3_142" class="t s2_142">Background: </span><span id="t4_142" class="t s0_142">Huntingtonâ€™s disease (HD) is a rare incurable progressive neurogenetic disorder caused by </span>
<span id="t5_142" class="t s0_142">repeated expansion of CAG trinucleotide in the huntingtin gene (Htt) with gradual loss of GABAergic </span>
<span id="t6_142" class="t s0_142">neurons in the striatal part of the basal ganglia. Agmatine is a novel neurotransmitter in the brain reported to </span>
<span id="t7_142" class="t s0_142">exhibit a diverse range of biological properties. </span>
<span id="t8_142" class="t s2_142">Materials and methods</span><span id="t9_142" class="t s0_142">: 3-nitropropionic acid (3-NP), a neurotoxin, was used to induce HD-like symptoms </span>
<span id="ta_142" class="t s0_142">in rats like progressive behavioral, biochemical, neurochemical, and histopathological alterations. Rats were </span>
<span id="tb_142" class="t s0_142">pre-treated with 3-NP (10 mg/kg, i.p.) on alternate days and then from the 10 </span>
<span id="tc_142" class="t s3_142">th </span>
<span id="td_142" class="t s0_142">day continued on agmatine </span>
<span id="te_142" class="t s0_142">treatment (5-20 mg/kg, i.p.) up to the 32 </span>
<span id="tf_142" class="t s3_142">nd </span>
<span id="tg_142" class="t s0_142">day of the treatment protocol. </span>
<span id="th_142" class="t s2_142">Results</span><span id="ti_142" class="t s0_142">: The findings of the current investigation revealed that the manifestations of HD induced by 3-NP </span>
<span id="tj_142" class="t s0_142">were restored by agmatine treatment. Agmatine intervention not only improved the 3-NP induced motor </span>
<span id="tk_142" class="t s0_142">incoordination, beam walking, rota-rod performance, and learning and memory impairment but also </span>
<span id="tl_142" class="t s0_142">normalized the GABA/glutamate levels as well as the oxidative stress markers in discrete brain areas. </span>
<span id="tm_142" class="t s0_142">Moreover, agmatine (20 mg/kg) ameliorates the observed histopathological changes and modulates the </span>
<span id="tn_142" class="t s0_142">expression of GFAP, a recognized immunohistochemical marker indicative of astrocytic activity. </span>
<span id="to_142" class="t s2_142">Discussion and conclusion</span><span id="tp_142" class="t s0_142">: The outcomes of the present study demonstrate that agmatine treatment </span>
<span id="tq_142" class="t s0_142">effectively counteracted HD manifestations induced by 3-NP. It ameliorated motor deficits, cognitive </span>
<span id="tr_142" class="t s0_142">impairments, and neurotransmitter dysregulations while restoring oxidative equilibrium. Notably, agmatine </span>
<span id="ts_142" class="t s0_142">exerted positive influences on histopathological alterations and GFAP modulation. These multifaceted </span>
<span id="tt_142" class="t s0_142">improvements underscore the </span>
<span id="tu_142" class="t s0_142">neuroprotective potential of agmatine for mitigating the diverse aspects of HD pathology. In conclusion, </span>
<span id="tv_142" class="t s0_142">agmatine holds enormous promise as a comprehensive therapeutic intervention for HD management, </span>
<span id="tw_142" class="t s0_142">warranting further exploration for clinical translation. </span>
<span id="tx_142" class="t s2_142">Acknowledgements: </span><span id="ty_142" class="t s0_142">I would like to express my heartfelt gratitude to my supervisor for their invaluable </span>
<span id="tz_142" class="t s0_142">support and guidance, which have been instrumental in shaping my progress. We also acknowledged the </span>
<span id="t10_142" class="t s0_142">DST-SERB (EEQ/2021/000955), New Delhi for generously providing the funding that enabled us to conduct </span>
<span id="t11_142" class="t s0_142">our research work. </span>
<span id="t12_142" class="t s4_142">P96: Early diagnosis of Alzheimerâ€™s disease by Electrocorticogram and ameliorative </span>
<span id="t13_142" class="t s4_142">effects of low intensity magnetic field stimulation in Streptozotocin rat model </span>
<span id="t14_142" class="t s2_142">Reena Chittora</span><span id="t15_142" class="t s0_142">, KP Kochhar </span>
<span id="t16_142" class="t s3_142">1 </span>
<span id="t17_142" class="t s0_142">, Suman Jain </span>
<span id="t18_142" class="t s0_142">Department of Physiology, All India Institute of Medical Sciences, New Delhi, India </span>
<span id="t19_142" class="t s2_142">Background: </span><span id="t1a_142" class="t s0_142">Alzheimerâ€™s disease (AD) is a progressive neurodegenerative disease and begins long before </span>
<span id="t1b_142" class="t s0_142">any symptoms become apparent. It is an irreversible brain disorder slowly compromising learning and </span>
<span id="t1c_142" class="t s0_142">memory skills. AD is an approaching public health crisis which presently lacks an effective treatment. </span>
<span id="t1d_142" class="t s0_142">Non-invasive, magnetic field stimulation therapy proposes a promising alternative approach to traditional </span>
<span id="t1e_142" class="t s0_142">pharmacological interventions for AD. </span>
<span id="t1f_142" class="t s2_142">Materials and Methods: </span><span id="t1g_142" class="t s0_142">Adult male Wistar rats were taken as study model and divided into three groups: </span>
<span id="t1h_142" class="t s0_142">Sham, AD and AD+MF. For development of AD, STZ was injected intracerebroventricularly, at a dose of </span>
<span id="t1i_142" class="t s0_142">3mg/kg body weight using stereotaxic apparatus. AD+MF animals were exposed to low intensity magnetic </span>
<span id="t1j_142" class="t s0_142">fields from 8th day of STZ treatment till 15th day. </span>
<span id="t1k_142" class="t s2_142">Results: </span><span id="t1l_142" class="t s0_142">A significant improvement in cognitive functions was observed following MF exposure in AD </span>
<span id="t1m_142" class="t s0_142">rats. The improvement in behaviour was supported by viable neuronal count which was higher after MF </span>
<span id="t1n_142" class="t s0_142">treatment than in the AD rats. Electrocorticogram from frontal and occipital lobes showed reduced delta </span>
<span id="t1o_142" class="t s0_142">power of EEG waves in AD rats, whereas, MF exposure for short duration of 8 days only, increased the </span>
<span id="t1p_142" class="t s0_142">wave power in comparison to AD. Significant neurogenesis was also evident in MF exposed rats. </span>
<span id="t1q_142" class="t s2_142">Discussion &amp; Conclusion: </span><span id="t1r_142" class="t s0_142">These findings illustrate that the alteration in delta activity can be a potential </span>
<span id="t1s_142" class="t s0_142">early diagnostic measure of cognitive impairment in AD. It further confirms the correlation of </span>
<span id="t1t_142" class="t s0_142">neurodegeneration with impaired memory deficits. Present findings also suggest that non-invasive </span>
<span id="t1u_142" class="t s0_142">magnetic field stimulation has the potential to ameliorate the functional, morphological and cognitive </span>
<span id="t1v_142" class="t s0_142">deficits in STZ rat model of AD. </span>
<span id="t1w_142" class="t s2_142">Acknowledgement: </span><span id="t1x_142" class="t s0_142">Authors wish to thank ICMR for financial assistance. The overall mentorship and </span>
<span id="t1y_142" class="t s0_142">supervision was provided by Prof. Suman Jain. </span></div>
<!-- End text definitions -->


</div>
</body>
</html>
